CUE - CIK 0001645460
Cue Biopharma, Inc. has filed 496 documents with the SEC between 2015 and 2026. The most frequent type is insider trade (196 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Employee stock plan | S-8 | 2025-08-12 | - |
| Quarterly report | 10-Q | 2025-08-12 | 2025-06-30 |
| Major company event | 8-K | 2025-08-12 | 2025-08-12 |
| Major company event | 8-K | 2025-07-01 | 2025-06-30 |
| Major company event | 8-K | 2025-06-10 | 2025-06-04 |
| Insider trade | 4 | 2025-06-06 | 2025-06-04 |
| New insider ownership | 3 | 2025-06-06 | 2025-06-04 |
| Proxy materials | DEFA14A | 2025-05-27 | - |
| SCHEDULE 13G/A | - | 2025-05-16 | - |
| Quarterly report | 10-Q | 2025-05-12 | 2025-03-31 |
| Major company event | 8-K | 2025-05-12 | 2025-05-12 |
| Annual report to shareholders | ARS | 2025-04-25 | 2024-12-31 |
| Proxy statement | DEF 14A | 2025-04-25 | 2025-06-03 |
| Proxy materials | DEFA14A | 2025-04-25 | - |
| Major company event | 8-K | 2025-04-15 | 2025-04-14 |
| Prospectus supplement | 424B5 | 2025-04-15 | - |
| Prospectus supplement | 424B5 | 2025-04-14 | - |
| Major company event | 8-K | 2025-04-14 | 2025-04-10 |
| PRE 14A | - | 2025-04-14 | 2025-04-14 |
| Employee stock plan | S-8 | 2025-03-31 | - |
| Major company event | 8-K | 2025-03-31 | 2025-03-31 |
| Annual report | 10-K | 2025-03-31 | 2024-12-31 |
| Insider trade | 4 | 2025-03-25 | 2025-03-21 |
| Insider trade | 4 | 2025-03-25 | 2025-03-21 |
| Insider trade | 4 | 2025-03-25 | 2025-03-21 |
| Insider trade | 4 | 2025-03-25 | 2025-03-21 |
| Insider trade | 4 | 2025-03-25 | 2025-03-21 |
| Insider trade | 4 | 2025-03-25 | 2025-03-21 |
| SCHEDULE 13G/A | - | 2025-03-21 | - |
| Insider trade | 4 | 2025-03-12 | 2025-03-10 |
| Major company event | 8-K | 2025-03-12 | 2025-03-10 |
| New insider ownership | 3 | 2025-03-12 | 2025-03-10 |
| SCHEDULE 13G/A | - | 2025-02-14 | - |
| Insider trade | 4 | 2025-01-03 | 2025-01-02 |
| Insider trade | 4 | 2025-01-03 | 2025-01-02 |
| Insider trade | 4 | 2025-01-03 | 2025-01-02 |
| Insider trade | 4 | 2025-01-03 | 2025-01-02 |
| Insider trade | 4 | 2025-01-03 | 2025-01-02 |
| Insider trade | 4 | 2024-12-18 | 2024-12-16 |
| SEC correspondence | UPLOAD | 2024-12-16 | - |
| Company correspondence | CORRESP | 2024-12-11 | - |
| SEC correspondence | UPLOAD | 2024-12-05 | - |
| Insider trade | 4 | 2024-11-29 | 2024-11-25 |
| New insider ownership | 3 | 2024-11-29 | 2024-11-25 |
| Quarterly report | 10-Q | 2024-11-14 | 2024-09-30 |
| Major company event | 8-K | 2024-11-14 | 2024-11-14 |
| Major company event | 8-K | 2024-10-08 | 2024-10-08 |
| SCHEDULE 13G/A | - | 2024-10-07 | - |
| Major company event | 8-K | 2024-10-04 | 2024-10-02 |
| Major company event | 8-K | 2024-09-27 | 2024-09-26 |